KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma
STOCKHOLM & LONDON--(BUSINESS WIRE)--Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a...